Highlights ► VEGF-D was expressed in all three GBC cell lines (GBC-SD, NOZ, and SGC-996). ► VEGF-D-RNAi-LV inhibited NOZ cells proliferation and invasion in vitro. ► VEGF-D-RNAi-LV inhibited tumor growth and lymphatic metastasis in xenograft model. ► VEGF-D-RNAi-LV inhibited tumor ascites and hepatic invasion in xenograft model. ► VEGF-D may be a potential molecular target in the treatment of GBC.
/lp/elsevier/vascular-endothelial-growth-factor-d-promotes-growth-lymphangiogenesis-uN7Tj1V4v8